The news of Morgan Stanley maintaining an Equal-Weight rating on Exelixis and raising the price target is likely to have a positive impact on the stock in the short term. This is because it indicates that the analyst sees potential in the company's stock and believes it is fairly valued. The increase in the price target also suggests that the analyst expects the stock price to rise in the future.